I'm excited that Compass has an experienced executive team in place to lead us through our phase 3 programme and prepare for a potential commercial launch, with Lori Englebert’s appointment, along with the recent additions of Teri Loxam and Michael Gold. Lori’s success in scaling commercial organisations across global functions will build on the work we have already begun to ensure broad and equitable access to new mental health treatments. I am delighted to welcome Lori to our leadership team, united by our mission to bring better options to people who urgently need them. Welcome to Compass, Lori!
We’re delighted to announce that Lori Englebert will be joining Compass as our new Chief Commercial Officer. Lori brings extensive experience in global pharmaceuticals and scaling commercial organisations. Together with Michael Gold and Teri Loxam, both of whom also recently joined Compass, as well as the existing members of the executive team, we have experienced leadership to lead us through our phase 3 programme and beyond. Read our press release: https://lnkd.in/ePay_XUM
Congrats to these key hires, Kabir and team!
Best of luck!
Best of luck!Great team
Kabir, longtime no see. Congratulations! Al
Executive Vice President, Chief Commercial and Strategy Officer at Seres Therapeutics
1moCongratulations Kabir. Wishing you and the team continued success!